- Home
- CMPS vs MLP Comparison
CMPS vs MLP Comparison
Compare CMPS & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- MLP
- Stock Information
- Founded
- CMPS 2020
- MLP 1909
- Country
- CMPS United Kingdom
- MLP United States
- Employees
- CMPS N/A
- MLP N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- CMPS Health Care
- MLP Finance
- Exchange
- CMPS Nasdaq
- MLP Nasdaq
- Market Cap
- CMPS 422.4M
- MLP 411.7M
- IPO Year
- CMPS 2020
- MLP 1972
- Fundamental
- Price
- CMPS $4.21
- MLP $19.79
- Analyst Decision
- CMPS Strong Buy
- MLP
- Analyst Count
- CMPS 6
- MLP 0
- Target Price
- CMPS $29.60
- MLP N/A
- AVG Volume (30 Days)
- CMPS 1.2M
- MLP 11.3K
- Earning Date
- CMPS 02-27-2025
- MLP 03-27-2025
- Dividend Yield
- CMPS N/A
- MLP N/A
- EPS Growth
- CMPS N/A
- MLP N/A
- EPS
- CMPS N/A
- MLP N/A
- Revenue
- CMPS N/A
- MLP $12,196,000.00
- Revenue This Year
- CMPS N/A
- MLP N/A
- Revenue Next Year
- CMPS N/A
- MLP N/A
- P/E Ratio
- CMPS N/A
- MLP N/A
- Revenue Growth
- CMPS N/A
- MLP 34.84
- 52 Week Low
- CMPS $3.17
- MLP $18.52
- 52 Week High
- CMPS $12.75
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- CMPS 48.38
- MLP 43.33
- Support Level
- CMPS $3.99
- MLP $19.36
- Resistance Level
- CMPS $4.88
- MLP $20.32
- Average True Range (ATR)
- CMPS 0.41
- MLP 0.66
- MACD
- CMPS -0.01
- MLP 0.02
- Stochastic Oscillator
- CMPS 26.89
- MLP 52.21
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.